Abstract
Inhaled Vasoactive Intestinal Peptide for Checkpoint Inhibitor Pneumonitis A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved...
Cite
CITATION STYLE
APA
Frye, B. C., Meiss, F., von Bubnoff, D., Zissel, G., & Müller-Quernheim, J. (2020). Vasoactive Intestinal Peptide in Checkpoint Inhibitor–Induced Pneumonitis. New England Journal of Medicine, 382(26), 2573–2574. https://doi.org/10.1056/nejmc2000343
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free